BioCentury
ARTICLE | Financial News

Clovis financial update

December 9, 2013 8:00 AM UTC

Clovis said shareholders sold 2 million shares at $57.50, or about $115 million, in a secondary offering underwritten by JPMorgan. Participating shareholders include LuxCapital V; Cooperatieve Aescap ...